Investor application

Mattel Announces Third Quarter 2023 Financial Results and Conference Call Date

Retrieved on: 
Wednesday, October 4, 2023

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2023 financial results on Wednesday, October 25, 2023, at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2023 financial results on Wednesday, October 25, 2023, at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a webcast conference call at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available under the Events and Presentations section of Mattel's Investor Relations website, https://investors.mattel.com .
  • An archive of the webcast will be available on the Company's website for 12 months following the event.

Mattel Announces Second Quarter 2023 Financial Results and Conference Call Date

Retrieved on: 
Thursday, July 6, 2023

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2023 financial results on Wednesday, July 26, 2023, at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2023 financial results on Wednesday, July 26, 2023, at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a webcast conference call at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available under the Events and Presentations section of Mattel's Investor Relations website, https://investors.mattel.com .
  • An archive of the webcast will be available on the Company's website for 12 months following the event.

Mattel Announces First Quarter 2023 Financial Results Conference Call

Retrieved on: 
Thursday, April 6, 2023

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its first quarter 2023 financial results on Wednesday, April 26, 2023, at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its first quarter 2023 financial results on Wednesday, April 26, 2023, at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a webcast conference call at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available under the Events and Presentations section of Mattel's Investor Relations website, https://investors.mattel.com .
  • To listen to the webcast, log on to the website at least 10 minutes early to register, download and install any necessary audio software.

Sarepta Therapeutics to Present at the Evercore ISI HealthCONx Conference

Retrieved on: 
Wednesday, November 23, 2022

CAMBRIDGE, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 2:15 p.m. E.T.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 2:15 p.m. E.T.
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
  • We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com .

Sarepta Therapeutics to Announce Third Quarter 2022 Financial Results

Retrieved on: 
Wednesday, October 26, 2022

CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2022 financial results after the Nasdaq Global Market closes on Wednesday, November 2, 2022.

Key Points: 
  • CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2022 financial results after the Nasdaq Global Market closes on Wednesday, November 2, 2022.
  • E.T., the Company will host a conference call to discuss its third quarter 2022 financial results.
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

Mattel Announces Third Quarter 2022 Financial Results Conference Call

Retrieved on: 
Thursday, October 6, 2022

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2022 financial results on Tuesday, October 25, 2022, at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2022 financial results on Tuesday, October 25, 2022, at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a webcast conference call at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available under the Events and Presentations section of Mattel's Investor Relations website, https://investors.mattel.com .
  • Mattel is a leading global toy company and owner of one of the strongest catalogs of childrens and family entertainment franchises in the world.

Sarepta Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Retrieved on: 
Tuesday, September 6, 2022

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. E.T.

Key Points: 
  • CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. E.T.
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
  • We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com .

Sarepta Therapeutics to Announce Second Quarter 2022 Financial Results and Recent Corporate Developments on August 2, 2022

Retrieved on: 
Tuesday, July 26, 2022

CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2022 financial results after the Nasdaq Global Market closes on Tuesday, August 2, 2022.

Key Points: 
  • CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2022 financial results after the Nasdaq Global Market closes on Tuesday, August 2, 2022.
  • E.T., the Company will host a conference call to discuss its second quarter 2022 financial results and to provide a corporate update.
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

Mattel Announces Second Quarter 2022 Financial Results Conference Call

Retrieved on: 
Wednesday, July 6, 2022

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2022 financial results on Thursday, July 21, 2022 at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2022 financial results on Thursday, July 21, 2022 at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a conference call webcast at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available on Mattel's Investor Relations website, https://investors.mattel.com .
  • Mattel is a leading global toy company and owner of one of the strongest catalogs of childrens and family entertainment franchises in the world.

Sarepta Therapeutics to Share New Clinical Data and Integrated Analysis for SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy on July 6, 2022 at 8:30am ET

Retrieved on: 
Tuesday, July 5, 2022

SRP-9001 is an investigational gene therapy for Duchenne being developed in partnership with Roche.

Key Points: 
  • SRP-9001 is an investigational gene therapy for Duchenne being developed in partnership with Roche.
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development.
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA, and gene editing.